Blood biomarker study in children with amblyopia
Part of Brain & nervous system, Eyes & vision clinical trials.
This trial looks at a blood test (a “biomarker”) in children with amblyopia, a common vision development problem. It may help researchers understand what changes go along with treatment and vision improvement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have been diagnosed with amblyopia
- Your child is between 3 and 12 years old
- Your child can take part in amblyopia treatment as advised
- You agree to follow-up visits about every 3 months
- You have no prior amblyopia treatment history before joining the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called AmblyoFix for children aged 7 to 12 with lazy eye (amblyopia) in one eye. The study aims to see if it helps improve vision better than standard care.
This trial tests a new treatment for children aged 8 to 12 with lazy eye (amblyopia) who have stopped standard treatments. The goal is to see if this therapy can improve vision in the weaker eye.
This trial tests whether a video treatment can improve “lazy eye” (amblyopia) in children ages 3–7. It may help if your child’s vision difference is present despite glasses worn consistently, and you’re able to skip the usual patching during the study.
This study looks at how changing your glasses prescription affects vision and visual function in adults with amblyopia (often called “lazy eye”). It may help researchers understand which optical correction best supports clearer, more balanced vision.
This trial studies whether perceptual learning and video-game style training can improve vision in people with amblyopia (lazy eye). You may be included if you have normal vision or amblyopia, and your eye exam does not show other eye problems that could affect results.
This trial is testing a new way to detect and prevent lazy eye (amblyopia) and other vision problems in young children. It uses a virtual reality headset to make screening easier.
Hear when a new Amblyopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.